Trinity Biotech Reports Strong Asset Growth

Trinity Biotech (TRIB) has released an update.

Trinity Biotech PLC has released its unaudited condensed consolidated financial statements for the period ending June 30, 2024, showing a significant increase in total assets to $94,355,000 from $59,435,000 at the end of the previous year. This financial growth is reflected in the rise of both non-current and current assets, including goodwill, intangible assets, and inventories. Shareholders will note an increase in share capital and share premium, despite a continued accumulated deficit.

For further insights into TRIB stock, check out TipRanks’ Stock Analysis page.